文献速递流行病学与生物统计真实世界研究与卫生经济

加速度计测量的体力活动、步数与癌症风险的剂量反应关系:英国生物银行前瞻性队列分析

Dose-response of accelerometer-measured physical activity, step count, and cancer risk in the UK Biobank: a prospective cohort analysis.
PubMed 文献 · Lancet · 2023-01-01

基于英国生物银行86556名佩戴腕部加速度计7天的参与者,随访平均6.1年,采用机器学习估算总体力活动与步数。总体力活动每增加1个标准差(+8.33毫重力/天),体力活动相关癌症风险降低(HR 0.85,95%CI 0.81-0.89);每日10000步相较5000步风险显著降低(HR 0.81,95%CI 0.73-0.90)。

要点

  • 总体力活动每增加1个标准差(+8.33毫重力/天),体力活动相关癌症风险HR为0.85(95%CI 0.81-0.89)。
  • 每日10000步相较5000步,体力活动相关癌症风险显著降低(HR 0.81,95%CI 0.73-0.90)。
  • 将其他活动时间重新分配为每天30分钟中高强度活动(HR 0.96,95%CI 0.94-0.98)或1小时轻度活动(HR 0.94,95%CI 0.92-0.96),均与较低癌症风险相关。

核心结论

  • 在该英国生物银行样本中,较高的总体力活动和每日步数与较低的体力活动相关癌症风险相关。
  • 研究结果提示,增加体力活动时间(无论强度如何)可能有益。
  • 作者认为,增加低强度活动时间和每日步数可能是降低癌症风险的实用公共卫生干预措施,尤其对老年人。

研究设计与样本

  • 前瞻性英国生物银行队列分析,纳入2013年6月1日至2015年12月23日期间佩戴腕部Axivity AX3加速度计7天、有有效数据且基线无癌症诊断的同意参与者。
  • 采用机器学习模型估算总体力活动(向量幅度)和步数,主要结局为13种既往与体力活动相关的癌症复合终点,来自国家登记处。
  • 使用Cox比例风险模型计算风险比(HR),以 attained age 为时间尺度,调整性别、族裔、吸烟状态、饮酒、教育程度和Townsend剥夺指数。
  • 采用成分数据分析评估行为间时间重新分配的影响,使用限制性立方样条评估剂量反应关系。

主要发现

  • 共分析86556名参与者,平均随访6.1年(年龄范围43-78岁;女性48478名[56%],男性38078名[44%];白人83830名[97%]),发生5577例新发恶性肿瘤。
  • 总体力活动每增加1个标准差(+8.33毫重力/天),体力活动相关癌症风险HR为0.85(95%CI 0.81-0.89)。
  • 相较于纳入参与者的平均行为构成,将每天30分钟从其他活动重新分配至中高强度体力活动,癌症风险HR为0.96(95%CI 0.94-0.98);将每天1小时重新分配至轻度强度活动,HR为0.94(95%CI 0.92-0.96)。
  • 相较于每日5000步,每日10000步与体力活动相关癌症风险显著降低相关(HR 0.81,95%CI 0.73-0.90)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Cancer is an age-related condition, but changes to modifiable lifestyle-related behaviours, including physical activity, could impact risk. While step count is an accessible metric of activity for older adults, its association with cancer risk remains poorly understood. We investigated the association between accelerometer-measured total activity, step count, and cancer risk. METHODS: We analysed data from a prospective UK Biobank cohort of consenting participants who wore wrist-based Axivity AX3 accelerometer devices for 7 days between June 1, 2013 and Dec 23, 2015, had valid accelerometer data, and no previous cancer diagnosis at baseline. Machine learning models estimated total physical activity (vector magnitude) and step count. The primary outcome, a composite of 13 cancers previously associated with physical activity, was obtained from national registries. Hazard ratios (HR) and were calculated using Cox proportional hazard models, with attained age as the underlying timescale and adjustment for sex, ethnicity, smoking status, alcohol consumption, education, and Townsend Deprivation Index. The impact of reallocating time between behaviours was evaluated using compositional data analyses. Dose-response associations were assessed with restricted cubic splines. FINDINGS: We analysed data from 86 556 participants, who were followed up during an average of 6·1 years (age range 43-78; 48 478 [56%] female and 38 078 [44%] male; 83 830 [97%] white). 5577 incident malignant cancers occurred among these 86 556 participants. Greater total physical activity was associated with a lower risk of physical-activity-related cancer (HR per 1 SD [+8·33 milligravity per day] 0·85, 95% CI 0·81-0·89). Reallocating 30 min/day from other activities to moderate-to-vigorous physical activity behaviour was associated with lower cancer risk (HR 0·96, 0·94-0·98), as was reallocating 1 h/day to light intensity activity (HR 0·94, 0·92-0·96), compared with the mean behaviour composition among included participants. Compared with taking 5000 steps per day, taking 10 000 daily steps was associated with a significantly lower risk of physical-activity-related cancer (HR 0·81, 0·73-0·90). INTERPRETATION: In this sample from the UK Biobank, higher total physical activity and daily step count were associated with lower risk of physical-activity-related cancers. Findings suggest additional physical activity time, irrespective of intensity, may be beneficial. Increasing low intensity activity time and increasing daily step counts could be practical public health interventions to lower cancer risk, especially for aging adults. FUNDING: National Institute of Health Oxford Cambridge Scholars Program, Wellcome Trust, Swiss Re, Health Data Research UK, and Cancer Research UK.

来源:Lancet,查看原文。版权归原作者所有。

引用

  1. Shreves AH, Small SR, Travis RC, et al. Dose-response of accelerometer-measured physical activity, step count, and cancer risk in the UK Biobank: a prospective cohort analysis. Lancet. 2023. PMID: 37997129. doi:10.1016/S0140-6736(23)02147-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。